What is HCPCS code M1063?

M1063 is the HCPCS Level II code for Patients receiving high doses of immunosuppressive therapy. It falls in Section M (Medical Services) of the 2026 HCPCS Level II code set maintained by CMS.

Is M1063 covered by Medicare?

Medicare coverage status for M1063 is: Carrier judgment. Always confirm current coverage with the payer.

Under Medicare Part B, M1063 is priced as: Not separately priced by Part B.

M1063 Patients receiving high doses of immunosuppressive therapy

Short descriptor: Pt rec hg dos imsup thpy

⚠ Terminated HCPCS Level II 2026

Terminated Code

M1063 was terminated as of 2020-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.

Open M1063 in the app →

Look up M1063 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

M1063 is the HCPCS Level II code for Patients receiving high doses of immunosuppressive therapy (2026). It belongs to Section M — Medical Services. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Not separately priced by Part B.

Classification & CMS Attributes

Section: M: Medical Services
Medicare Coverage: Carrier judgment (code C)
Part B Pricing: Not separately priced by Part B (indicator 00)
Type of Service: Medical care
Effective Date: 2021-01-01
Termination Date: 2020-12-31
2026 Maintenance: No change this year

References

Cite This Page

Reference M1063 with the canonical source and edition:

M1063 — Patients receiving high doses of immunosuppressive therapy. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/M1063

Canonical URL: https://icd10codingpro.com/hcpcs-codes/M1063

M1063 Patients receiving high doses of immunosuppressive therapy

Classification & CMS Attributes

References

Cite This Page

Related Codes in Section M

Get HCC Mappings, Clinical Summaries, and More